openPR Logo
Press release

Veterinary Infectious Disease Diagnostics Market Trend & Worth USD 3.76 Billion in 2030 - Report by Emergen Research

05-03-2023 04:51 PM CET | Health & Medicine

Press release from: Emergen Research

Veterinary Infectious Disease Diagnostics Market

Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics Market is a rapidly growing sector that plays a critical role in the prevention and control of infectious diseases in animals. The market includes various diagnostic tests, such as molecular diagnostics, immunodiagnostics, and others, that are used to detect, monitor, and manage infectious diseases in animals.

Overview:

The global Veterinary Infectious Disease Diagnostics Market is expected to grow significantly in the coming years. The market is primarily driven by the increasing prevalence of infectious diseases in animals, rising demand for animal-derived food products, and growing awareness about zoonotic diseases. Additionally, advancements in diagnostic technologies and the emergence of new and innovative diagnostic tests are also driving the growth of the market.

Drivers:

One of the major drivers of the Veterinary Infectious Disease Diagnostics Market is the increasing prevalence of infectious diseases in animals. Infectious diseases can have a significant impact on animal health, causing significant economic losses for livestock farmers and threatening food security. As a result, there is a growing demand for effective diagnostic tests that can detect and manage these diseases. Additionally, the increasing demand for animal-derived food products, such as meat, dairy, and eggs, is also driving the growth of the market.

Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures)@ https://www.emergenresearch.com/request-sample/1824

Restraints:

Despite the growth potential of the Veterinary Infectious Disease Diagnostics Market, there are several factors that may restrain its growth. The high cost of diagnostic tests and the lack of skilled professionals may limit the adoption of these tests, particularly in developing countries. Additionally, the lack of standardization and harmonization of diagnostic protocols may hinder the growth of the market.

Growth Factors:

The Veterinary Infectious Disease Diagnostics Market is expected to grow significantly in the coming years due to several growth factors. These include the increasing prevalence of infectious diseases in animals, growing demand for animal-derived food products, and advancements in diagnostic technologies. Additionally, the rising awareness about zoonotic diseases and the need for early detection and control of these diseases are also driving the growth of the market. Furthermore, the emergence of new and innovative diagnostic tests is also expected to drive the growth of the market.

Statistics:

According to the World Organisation for Animal Health (OIE), around 60% of all human infectious diseases are of animal origin. Additionally, the OIE estimates that infectious diseases in animals cause losses of around $300 billion annually. These statistics highlight the critical need for effective diagnostic tests to manage and control infectious diseases in animals.

Major Companies and Competitive Landscape:

The Veterinary Infectious Disease Diagnostics Market is highly competitive, with several players competing for market share. Some of the key players in the market include IDEXX, Thermo Fisher Scientific, Heska Corporation, Neogen Corporation, QIAGEN, Randox Laboratories Ltd, BIOMÉRIEUX, Virbac, Zoetis, and BioChek.

IDEXX Laboratories, Inc. is one of the leading players in the Veterinary Infectious Disease Diagnostics Market, offering a wide range of diagnostic tests for infectious diseases in animals. The company's product portfolio includes the SNAP tests, which are rapid and accurate tests for the detection of various infectious diseases in animals.

Zoetis, Inc. is another major player in the market, offering a broad range of veterinary diagnostic products for infectious diseases, including the Diagnostics Portfolio, which includes tests for various infectious diseases, such as Lyme disease, leptospirosis, and parvovirus.

Thermo Fisher Scientific, Inc. is also a key player in the Veterinary Infectious Disease Diagnostics Market, offering a wide range of diagnostic tests, including the VetMAX™-Gold SIV Detection Kit, which is a PCR-based test for the detection of swine influenza virus.

Heska Corporation is a leading provider of veterinary diagnostic products and services, offering a range of diagnostic tests, including the Element DC and DRI-CHEM immunoassay analyzers, which are used for the detection of various infectious diseases in animals.

Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics, offering a range of veterinary diagnostic products, including the BioPlex 2200 System, which is a multiplex assay system for the detection of infectious diseases in animals.

Neogen Corporation is a provider of diagnostic products and services for the food and animal safety industries, offering a range of veterinary diagnostic products, including the AccuPoint Advanced ATP Hygiene Monitoring System, which is a rapid hygiene monitoring system used to detect ATP on surfaces.

Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/1824

Segmentation Insights for Veterinary Infectious Disease Diagnostics Market Report:

The technology outlook for the Veterinary Infectious Disease Diagnostics Market includes immunodiagnostics, lateral flow assays, ELISA tests, molecular diagnostics, PCR tests, and microarrays. The revenue generated by these technologies is expected to increase significantly from USD Billion in 2019 to USD Billion by 2030. The growing demand for accurate and rapid diagnostic tests for infectious diseases in animals is expected to drive the growth of these technologies.

In terms of animal type outlook, the Veterinary Infectious Disease Diagnostics Market is segmented into companion animals and food-producing animals. The revenue generated by the diagnostic tests for companion animals is expected to increase significantly from USD Billion in 2019 to USD Billion by 2030, due to the growing demand for pet healthcare services. Similarly, the revenue generated by the diagnostic tests for food-producing animals is also expected to increase from USD Billion in 2019 to USD Billion by 2030, due to the growing concern over food safety.

The end-use outlook for the Veterinary Infectious Disease Diagnostics Market includes veterinary hospitals & clinics, veterinary reference laboratories, point of care/in-house testing, and veterinary research institutes & universities. The revenue generated by these end-use segments is expected to increase significantly from USD Billion in 2019 to USD Billion by 2030. The growing awareness among pet owners and farmers about the importance of timely diagnosis of infectious diseases in animals is expected to drive the growth of these segments.

Geographically, the Veterinary Infectious Disease Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The revenue generated by these regions is expected to increase significantly from USD Billion in 2019 to USD Billion by 2030. North America is expected to dominate the market during the forecast period, due to the presence of major players in the region and the growing demand for pet healthcare services. Similarly, Asia Pacific is also expected to witness significant growth during the forecast period, due to the growing demand for food safety and increasing pet ownership in the region.

View the Full Report Description, the Research Methodology, the Content Table, and the Infographics @ https://www.emergenresearch.com/industry-report/veterinary-infectious-disease-diagnostics-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Veterinary Infectious Disease Diagnostics Market Trend & Worth USD 3.76 Billion in 2030 - Report by Emergen Research here

News-ID: 3039638 • Views:

More Releases from Emergen Research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion in 2023, Set for Strong Growth at 16.5% CAGR
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems. The market is also benefiting from the
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13.6% CAGR
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions. Stem cell therapies offer the ability to repair, replace, or restore damaged tissues
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophisticated
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing at 13.9% CAGR
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia. Once seen as

All 5 Releases


More Releases for Infectious

Infectious Disease Therapeutics Market - Infectious Disease Solutions: Revolutio …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Infectious Disease Therapeutics Market. Infectious Disease Therapeutics Market: https://www.growthplusreports.com/report/infectious-disease-therapeutics-market/9210 The Infectious Disease Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Infectious Disease Diagnostics Market Owing to the Increasing Prevalence of Infe …
According to Precision Business Insights (PBI) latest report, the infectious disease diagnostics market is expected to be worth USD 34,599.0 million in 2022, growing at a 6.4% CAGR from 2022 to 2028. Global Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments and Software & Services), By Type of Testing (Laboratory Testing and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63 The U.S. FDA (United States Food and Drug Administration) is
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased